|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.15 USD | +4.03% |
|
+4.89% | +31.93% |
| 07-15 | Bruker Acquires Noscendo's Disqver Clinical Metagenomics Platform | MT |
| 07-14 | Bruker Corporation acquired DISQVER Clinical Metagenomics Platform of Noscendo GmbH. | CI |
| Market Cap | 9.46B 8.32B 7.73B 7.11B 13.33B 916B 13.57B 92.43B 36.05B 447B 35.52B 34.75B 1,550B | P/E 2026 * |
61.4x | P/E 2027 * | 46.6x |
|---|---|---|---|---|---|
| Enterprise Value | 10.94B 9.62B 8.94B 8.22B 15.42B 1,060B 15.7B 107B 41.7B 517B 41.08B 40.19B 1,793B | EV / Sales 2026 * |
3.05x | EV / Sales 2027 * | 2.87x |
| Free-Float |
60.72% | Yield 2026 * |
0.32% | Yield 2027 * | 0.33% |
Last Transcript: Bruker Corporation
| 1 day | +4.03% | ||
| 1 week | +4.89% | ||
| Current month | +3.27% | ||
| 1 month | +12.77% | ||
| 3 months | +71.59% | ||
| 6 months | +23.48% | ||
| Current year | +31.93% |
| 1 week | 54.8 |  | 63.48 |
| 1 month | 54.8 | | 63.48 |
| Current year | 32.36 | | 64.54 |
| 1 year | 28.53 | | 64.54 |
| 3 years | 28.53 | | 94.86 |
| 5 years | 28.53 | | 94.86 |
| 10 years | 19.58 | | 94.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Laukien
CEO | Chief Executive Officer | 66 | 1991-01-31 |
Gerald Herman
DFI | Director of Finance/CFO | 68 | 2018-03-16 |
Thorsten Thiel
SAM | Sales & Marketing | - | 2010-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
William Linton
BRD | Director/Board Member | 79 | 2000-01-31 |
Frank Laukien
CHM | Chairman | 66 | 1991-01-31 |
Richard Packer
BRD | Director/Board Member | 68 | 2007-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 | Fiscal year | Executive/Senior Manager | 6,000 | 0.0039% | ||
| 7/1/26 | Other | President BMID Group | 10,154 | 0.0067% | ||
| 6/15/26 | Fiscal year | Executive/Senior Manager | 6,000 | 0.0039% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.03% | +4.89% | +55.73% | -17.54% | 9.46B | |
| +8.71% | +5.36% | +22.63% | +1.80% | 213B | |
| +7.46% | -6.10% | -2.72% | -24.77% | 135B | |
| -2.54% | -17.48% | -33.85% | -1.38% | 117B | |
| +1.42% | -2.33% | -59.56% | -18.02% | 64.78B | |
| -0.65% | -4.58% | +8.98% | -9.45% | 48.26B | |
| +1.51% | -1.88% | -28.06% | -32.75% | 43.08B | |
| +4.71% | +2.67% | +16.97% | +9.50% | 39.47B | |
| +3.13% | +1.12% | +29.35% | +32.45% | 37.55B | |
| +3.14% | +3.47% | +88.18% | +3.34% | 29.78B | |
| Average | +2.20% | -2.54% | +9.76% | -5.68% | 73.77B | |
| Weighted average by Cap. | +2.03% | -4.78% | +1.04% | -6.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.59B 3.16B 2.93B 2.7B 5.06B 348B 5.15B 35.07B 13.68B 170B 13.47B 13.18B 588B | 3.74B 3.29B 3.06B 2.81B 5.27B 362B 5.37B 36.56B 14.26B 177B 14.05B 13.74B 613B |
| Net income | 155M 136M 127M 116M 218M 15.01B 222M 1.51B 590M 7.32B 582M 569M 25.39B | 203M 179M 166M 153M 286M 19.67B 291M 1.98B 774M 9.6B 763M 746M 33.29B |
| Net Debt | 1.48B 1.3B 1.21B 1.11B 2.09B 143B 2.12B 14.46B 5.64B 69.92B 5.56B 5.44B 243B | 1.27B 1.12B 1.04B 954M 1.79B 123B 1.82B 12.4B 4.84B 59.95B 4.77B 4.66B 208B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$62.15 | +4.03% | 1,689,026 |
| 26-07-22 | US$59.74 | -1.14% | 1,350,550 |
| 26-07-21 | US$60.43 | +7.58% | 2,775,002 |
| 26-07-20 | US$56.17 | -3.54% | 1,838,859 |
| 26-07-17 | US$58.23 | -1.72% | 2,325,641 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BRKR Stock
Select your edition
All financial news and data tailored to specific country editions
